NEWS
Verrica Pharmaceuticals to Report Second Quarter Financial Results and Release Preliminary Topline Results from Part 2 of Phase 2 Trial of VP-315 for the Treatment of Basal Cell Carcinoma on August 14, 2024
VRCA), a dermatology therapeutics company, has announced a conference call and webcast scheduled for August 14, 2024, at 8:30 a.m. ET. The event will cover two main topics:
1. The company's financial results for the second quarter ended June 30, 2024.
2. An overview of preliminary topline results from Part 2 of the Phase 2 trialof VP-315 for the treatment of basal cell carcinoma.
Interested parties can join via phone or webcast. The webcast will be archived on Verrica's website for 90 days after the event.
1. The company's financial results for the second quarter ended June 30, 2024.
2. An overview of preliminary topline results from Part 2 of the Phase 2 trialof VP-315 for the treatment of basal cell carcinoma.
Interested parties can join via phone or webcast. The webcast will be archived on Verrica's website for 90 days after the event.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2311Followers
105Following
24KVisitors
Follow